Close Menu

NEW YORK (GenomeWeb) – Abbott said today that it intends to close the acquisition of Alere on Tuesday, Oct. 3, after receiving all needed regulatory clearances.

The announcement follows a flurry of activity on Thursday that saw Abbott and Alere receive clearances, some conditional, from the US Department of Justice, US Federal Trade Commission, and the US Securities and Exchange Commission.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.